In April 2026, Elevance Health reported first-quarter revenue of US$50.18 billion, down in profitability with diluted EPS ...
Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnings ...
Elevance Health (ELV) stock slips even as the company posts better than expected Q1 2026 results and lifts its full-year ...
Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook
Elevance Health Inc. (NYSE:ELV) on Tuesday reported first-quarter 2025 revenues of $48.77 billion, up 15% year-over-year, higher than the consensus of $46.29 billion. The increase was driven by higher ...
StockStory.org on MSN
ELV Q1 deep dive: Operating discipline and AI integration drive margin expansion
Health insurance provider Elevance Health (NYSE:EVH) reported Q1 CY2026 results , with sales up 2.9% year on year to $50.18 ...
Hotchkis & Wiley, an investment management company, released its first-quarter 2026 investor letter for the “Hotchkis & Wiley ...
Fintel on MSN
B of A Securities Upgrades Elevance Health (ELV)
Fintel reports that on April 29, 2026, B of A Securities upgraded their outlook for Elevance Health (NYSE:ELV) from Neutral ...
Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors ...
Investors in Elevance Health Inc (Symbol: ELV) saw new options begin trading today, for the January 2028 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, ...
CHONGQING, CHINA - JULY 13: In this photo illustration, a smartphone displaying the logo of Elevance Health, Inc. (NYSE: ELV), a major American health insurance provider and parent company of Anthem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results